← Leaderboards
Junior Arturo Gonzales-Arevalo
Sloan-Kettering Inst Can Research
$407,334
Attributed
$407,334
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$407,334 · 2
By mechanism
R00$249,000 · 1
K99$158,334 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Thomas Reiner$4,804,085
- Michelle S Bradbury$7,087,200
- Hakim Djaballah$6,137,816
- Abdelkrim K. Touijer$456,703
- Ulrich Wiesner$4,616,977
Others in their field
Other Emerging Leaders on “Anticancer Research”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Leonard Freedmand · Leidos Biomedical Research, Inc.$22,652,885
Research focus
Anticancer ResearchAccidentsAthletic InjuriesBacteriochlorinAssaultBinding ProteinsBiochemicalBiodistributionBioimagingBiologicalBiological MarkersBiopsyBlast InjuriesBrainCancer BiologyCancer CellCancer DiagnosisCancer EtiologyCancer PatientCancer SurvivorCancer TypeCareerCastration Resistant Prostate CancerCells
Grant awards (3)
Validation of an Intraoperative Neuro-Monitoring Contrast Agent for Cranial Nerves$249,000
R00 · FY2023 · GM · contact PI
Development of multimodal agents from natural spider peptides for prostate cancer via sodium-channel NaV1.7$58,334
K99 · FY2022 · GM · contact PI
Development of multimodal agents from natural spider peptides for prostate cancer via sodium-channel NaV1.7$100,000
K99 · FY2021 · GM · contact PI